Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Andreone

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Experimental & Clinical Cancer Research : CR|May 2, 2025
Decitabine co-operates with the IL-33/ST2 axis modifying the tumor microenvironment and improving the response to PD-1 blockade in melanomaFrancesco Noto, Jacopo Mancini, Adriana Rosa Gambardella, et al.
Cells|April 30, 2021
Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor ModelsMaria Ciccolella, Sara Andreone, Jacopo Mancini, et al.
Cancers|November 14, 2019
IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell KillingSara Andreone, Francesca Spadaro, Carla Buccione, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 26, 2024
IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cellsAdriana Rosa Gambardella, Caterina Antonucci, Cristiana Zanetti, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Experimental & Clinical Cancer Research : CR|May 2, 2025
Decitabine co-operates with the IL-33/ST2 axis modifying the tumor microenvironment and improving the response to PD-1 blockade in melanomaFrancesco Noto, Jacopo Mancini, Adriana Rosa Gambardella, et al.
Cells|April 30, 2021
Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor ModelsMaria Ciccolella, Sara Andreone, Jacopo Mancini, et al.
Cancers|November 14, 2019
IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell KillingSara Andreone, Francesca Spadaro, Carla Buccione, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 26, 2024
IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cellsAdriana Rosa Gambardella, Caterina Antonucci, Cristiana Zanetti, et al.
Pageof 2